Telehealth only reduces costs for certain types of diseases

Researchers at the University of Texas at Austin found that telehealth did not reduce costs or the number of future visits for patients with circulatory, respiratory or infectious diseases.

Advertisement

The researchers based their findings on patient visits from hospital outpatient clinics in Maryland from 2012 to 2021. Telehealth tools were effective at treating behavioral health conditions, metabolic disorders, dermatology and musculoskeletal disorders, according to a July 12 University of Texas at Austin news release.

Overall, the study did find that telehealth reduced outpatient costs by $239 per patient. However, clinicians could not accurately observe heart and lung conditions or deal with infections over video.

“People believed that telehealth would be the next big thing, the future of healthcare,” Indranil Bardhan, PhD, a professor of information, risk and operations management, said in the release. “But our research shows that its impact is not as straightforward as people might think. It’s more nuanced.”

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

How Allina Health is building the operating system for AI transformation — and driving $7.3M in added annual surgical contribution margin

Wednesday, July 29
1:00 PM - 2:00 PM CDT

Presenters: William Evans, Allina HealthDonna Sajady, Allina HealthDavid Atashroo, MD, Qventus

Advertisement

Next Up in Telehealth

Advertisement

Comments are closed.